Courtesy Story | Defense Threat Reduction Agency's Chemical and Biological Technologies Department | 08.12.2024
To help remedy the cumbersome, time-consuming, and expense of creating new drugs against biological pathogens, research into artificial intelligence (AI), machine learning (ML), and deep learning (DL) technologies have allowed scientists to focus on rapid drug design and development by combining DL with the principles of geometry to reduce failure rates, length of schedule, and cost-associated......
